Pharmacotherapy of Bipolar Disorder with Quetiapine: A Recent Literature Review and an Update

The bipolar spectrum: Conceptions and misconceptions

(2014) S Nassir Ghaemi et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Effect of hyperglycaemia on muscarinic M3 receptor expression and secretory sensitivity to cholinergic receptor activation in islets

(2014) A. C. Hauge-Evans et al.   DIABETES OBESITY & METABOLISM

Clinical course of the bipolar II disorder in a Japanese sample

(2014) Akeo Kurumaji et al.   JOURNAL OF AFFECTIVE DISORDERS

Efficacy and Safety of Quetiapine-XR as Monotherapy or Adjunctive Therapy to a Mood Stabilizer in Acute Bipolar Depression With Generalized Anxiety Disorder and Other Comorbidities

(2014) Keming Gao et al.   JOURNAL OF CLINICAL PSYCHIATRY

Acute and Maintenance Treatments for Bipolar Depression

(2014) Terence A. Ketter   JOURNAL OF CLINICAL PSYCHIATRY

Quetiapine for acute bipolar depression: a systematic review and meta-analysis

(2014) Sirijit Suttajit et al.   Drug Design Development and Therapy

Potential Molecular and Cellular Mechanism of Psychotropic Drugs

(2014) Myoung Suk Seo et al.   Clinical Psychopharmacology and Neuroscience

Treatment Patterns, HealthCare Resource Utilization and Costs in Patients with Bipolar Disorder, Newly Treated with Extended Release or Immediate Release Quetiapine Fumarate using US Healthcare Administrative Claims Data

(2013) Julie C. Locklear et al.   CLINICAL THERAPEUTICS

Serotonergic Drugs for Depression and Beyond

(2013) Stephen M. Stahl et al.   CURRENT DRUG TARGETS

Pharmacokinetic profile of the extended-release formulation of quetiapine fumarate (quetiapine XR): clinical implications

(2013) Khanh Bui et al.   CURRENT MEDICAL RESEARCH AND OPINION

MAINTENANCE TREATMENT WITH QUETIAPINE WHEN COMBINED WITH EITHER LITHIUM OR DIVALPROEX IN BIPOLAR I DISORDER: ANALYSIS OF TWO LARGE RANDOMIZED, PLACEBO-CONTROLLED TRIALS

(2013) Trisha Suppes et al.   DEPRESSION AND ANXIETY

Clinical management and burden of bipolar disorder: results from a multinational longitudinal study (WAVE-bd)

(2013) Eduard Vieta et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Prevalence, chronicity, burden and borders of bipolar disorder

(2013) Andrea Fagiolini et al.   JOURNAL OF AFFECTIVE DISORDERS

Efficacy and Safety of Quetiapine in Children and Adolescents With Mania Associated With Bipolar I Disorder

(2013) Sanjeev Pathak et al.   JOURNAL OF CLINICAL PSYCHIATRY

Norquetiapine and Depressive Symptoms in Initially Antipsychotic-Naive First-Episode Schizophrenia

(2013) Hans Rasmussen et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Quetiapine for the treatment of delirium

(2013) Stefanie B. Hawkins et al.   Journal of Hospital Medicine

Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010

(2013) Harvey A Whiteford et al.   LANCET

Bipolar disorder and co-occurring cannabis use disorders: Characteristics, co-morbidities and clinical correlates

(2013) Shaul Lev-Ran et al.   PSYCHIATRY RESEARCH

Active Metabolites as Antidepressant Drugs: The Role of Norquetiapine in the Mechanism of Action of Quetiapine in the Treatment of Mood Disorders

(2013) Francisco López-Muñoz et al.   Frontiers in Psychiatry

Update on Typical and Atypical Antipsychotic Drugs

(2012) Herbert Y. Meltzer   Annual Review of Medicine

Effect of Quetiapine and Norquetiapine on Anxiety and Depression in Major Psychoses Using a Pharmacokinetic Approach

(2012) A. Carlo Altamura et al.   CLINICAL DRUG INVESTIGATION

Quetiapine

(2012) Mark Sanford et al.   CNS DRUGS

Role of concomitant inhibition of the norepinephrine transporter for the antipsychotic effect of quetiapine

(2012) Carl Björkholm et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Long-term efficacy of quetiapine in combination with lithium or divalproex on mixed symptoms in bipolar I disorder

(2012) Eduard Vieta et al.   JOURNAL OF AFFECTIVE DISORDERS

Quetiapine

(2012) Greg L. Plosker   PHARMACOECONOMICS

A randomised, placebo-controlled 52-week trial of continued quetiapine treatment in recently depressed patients with bipolar I and bipolar II disorder

(2012) Allan H. Young et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Quetiapine and Buspirone Both Elevate Cortical Levels of Noradrenaline and Dopamine In vivo, but Do Not have Synergistic Effects

(2012) P. H. Silverstone et al.   Frontiers in Psychiatry

Extended-Release Quetiapine as Monotherapy for the Treatment of Adults With Acute Mania: A Randomized, Double-Blind, 3-Week Trial

(2011) Andrew J. Cutler et al.   CLINICAL THERAPEUTICS

Optimal Frequency of Lithium Administration in the Treatment of Bipolar Disorder

(2011) Gin S. Malhi et al.   CNS DRUGS

Quetiapine Extended Release

(2011) Mark Sanford   CNS DRUGS

Continuation of Quetiapine Versus Switching to Placebo or Lithium for Maintenance Treatment of Bipolar I Disorder

(2011) Richard H. Weisler et al.   JOURNAL OF CLINICAL PSYCHIATRY

Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A placebo-controlled, randomized study☆

(2010) Brian Bortnick et al.   JOURNAL OF AFFECTIVE DISORDERS

A Double-Blind, Placebo-Controlled Study of Quetiapine and Paroxetine as Monotherapy in Adults With Bipolar Depression (EMBOLDEN II)

(2010) Susan L. McElroy et al.   JOURNAL OF CLINICAL PSYCHIATRY

A Double-Blind, Placebo-Controlled Study of Quetiapine and Lithium Monotherapy in Adults in the Acute Phase of Bipolar Depression (EMBOLDEN I)

(2010) Allan H. Young et al.   JOURNAL OF CLINICAL PSYCHIATRY

Cost Effectiveness of Adjunctive Quetiapine Fumarate Extended-Release Tablets with Mood Stabilizers in the Maintenance Treatment of Bipolar I Disorder

(2010) Tatia Chay Woodward et al.   PHARMACOECONOMICS

Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression

(2009) Trisha Suppes et al.   JOURNAL OF AFFECTIVE DISORDERS